reference/29008550

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/29008550

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
issn	1946-6242 1946-6234
issueIdentifier	367
pageRange	367ra166-
publicationName	Science Translational Medicine
startingPage	367ra166
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_28ba92ba2d48178cf87b6cfa67ccf94a http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c65507462140f46e3d0a56140cf565dc http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_1543594250103bcc791139fc700bf5a5 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a7f541fe2412e12d7954d92434e08359
bibliographicCitation	Arenas-Ramirez N, Zou C, Popp S, Zingg D, Brannetti B, Wirth E, Calzascia T, Kovarik J, Sommer L, Zenke G, Woytschak J, Regnier CH, Katopodis A, Boyman O. Improved cancer immunotherapy by a CD25-mimobody conferring selectivity to human interleukin-2. Sci Transl Med. 2016 Nov 30;8(367):367ra166. doi: 10.1126/scitranslmed.aag3187. PMID: 27903862.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c9c2a92ab35d7d07d3b18bdc178aa2f9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4cf9557aa6d4273162751e18321c7e08 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_019820da5ac658b0f8fe05268b61aa41 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ef21aab107620c62109b3c732dc3ea2d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f662eda13fd748be88784c9b3e933e79 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7d2a3d1ec12f843b5360feec6290850a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_92b3fac674a7eaa2b9cfff8cc2281b0c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3e4f7093f892ae81f89647a92bd49a94 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1c59a998ed672b2d9a367d34d119691a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_640b53d9eea890e9576dad7c0bc651d4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5cd6a895246ea79500fd0078520ff762 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-8225-6744 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4357e84220005b112ff1f25f7534177f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5f4265f8ac88a047e9163658bd272cba http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e6149b63665d331890241a8580e98201 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-4415-5605
date	2016-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1126/scitranslmed.aag3187 https://pubmed.ncbi.nlm.nih.gov/27903862
isPartOf	https://portal.issn.org/resource/ISSN/1946-6234 https://portal.issn.org/resource/ISSN/1946-6242 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/36963
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Improved cancer immunotherapy by a CD25-mimobody conferring selectivity to human interleukin-2
discusses	http://id.nlm.nih.gov/mesh/M0495059 http://id.nlm.nih.gov/mesh/M0495923 http://id.nlm.nih.gov/mesh/M0001403 http://id.nlm.nih.gov/mesh/M0001357 http://id.nlm.nih.gov/mesh/M0404923 http://id.nlm.nih.gov/mesh/M0011506
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D009369Q000628 http://id.nlm.nih.gov/mesh/D053645Q000276 http://id.nlm.nih.gov/mesh/D007376Q000037 http://id.nlm.nih.gov/mesh/D000911Q000737 http://id.nlm.nih.gov/mesh/D007167Q000379
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D008546Q000628 http://id.nlm.nih.gov/mesh/D008810 http://id.nlm.nih.gov/mesh/D008546Q000276 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D011995 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D008807 http://id.nlm.nih.gov/mesh/D013602Q000166 http://id.nlm.nih.gov/mesh/D009369Q000276 http://id.nlm.nih.gov/mesh/D020868 http://id.nlm.nih.gov/mesh/D001665 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D000939Q000737 http://id.nlm.nih.gov/mesh/D011487 http://id.nlm.nih.gov/mesh/D049109 http://id.nlm.nih.gov/mesh/D018414Q000166 http://id.nlm.nih.gov/mesh/D008822 http://id.nlm.nih.gov/mesh/D050378Q000276
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_29f84c0d894769b14b36c5f43f54153e http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_79e09a32844b73c7802d9d5b7645ff63 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_0d1c0203c86182a45fb1c6272bbe1d33 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_73585e53d5ee34809e0274cb21425976 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7706 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8448 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_ea6f5eeb3cd76d944294f1c0f75ab895 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7d6a1edc08997e3d7b61d7a07051efb5

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID110066 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID19373 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID21577 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID20431

Total number of triples: 80.